National Advisory Committee

Maria Inês Almeida

INEB/i3S/ICBAS – University of Porto, Portugal

Cecília Juliana Alves

Instituto de Investigação e Inovação em Saúde NeuroSkeletal Circuits group, Portugal

Isabel Freitas Amaral

INEB / i3S, University of Porto, Portugal

David Barata

Instituto Medicina Molecular, Portugal

Mário Adolfo Barbosa

University of Porto, Portugal

Ana Bettencourt

Faculty Fharmacy, Lisboa, Portugal

Sílvia Joana Bidarra

i3S Bioengineered 3D Microenvironments, Portugal

João Borges

Nova University of Lisboa, Portugal

Hugo Caires

i3s/ IPATIMUP – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Portugal

Joana Caldeira

INEB/i3S, Portugal

Angela Carvalho

INEB/i3S, Portugal

Flávia Castro

i3S – Instituto de Investigação e Inovação em Saúde, Portugal

Carla Cunha

INEB/i3S, Portugal

Tiago dos Santos

INEB, Portugal

Jose Paulo Farinha

Instituto Superior Tecnico, University of Lisbon, Portugal

Maria Helena Vaz Fernandes

University of Aveiro, Portugal

Lino Silva Ferreira

University of Coimbra, Portugal

Jaime Freitas

INEB/i3S, Portugal

Miguel Gama

University of Minho, Portugal

Manuela Gomes

3B’s Research Group-University of Minho I3Bs Research Institute, Portugal

Paula Gomes

University of Porto, Portugal

Pedro L. Granja

Instituto de Investigação e Inovação em Saúde (i3S) da Universidade do Porto, Portugal

Subhas C. Kundu

University of Minho 3Bs Research Group, Portugal

Victoria Leiro

i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto INEB – Instituto de Engenharia Biomédica, Portugal

Claudia Lobato

IST, University of Lisbon, Portugal

Bianca N. Lourenço

INEB – Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Portugal

João Mano

University of Aveiro, Portugal

Alexandra P. Marques

University of Minho 3B’s Research Group, Portugal

Paula Alexandrina Marques

University of Aveiro, Portugal

Cristina Lopes Martins

INEB – Instituto de Engenharia Biomedica i3S- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal

Claudia Monteiro

i3S, Instituto de Investigação e Inovação em Saude, Portugal

Pedro Moreno

i3S/INEB, Portugal

Diana S Nascimento

INEB – Instituto de Engenharia Biomédica, Portugal

Estrela Neto

INEB/i3S, Portugal

Ana Oliveira

Catholic University, Portugal

Miguel Oliveira

University of Minho Institute 3Bs, Portugal

Maria do Carmo Pereira

University of Porto, Portugal

Andreia Trindade Pereira

INEB/i3S – Instituto de Engenharia Biomédica, Portugal

Rúben F. Pereira

ICBAS/i3S, Portugal

Artur Pinto

LEPABE, Faculty of Engineering, University of Porto Chemical Engineering, Portugal

Perpetua Pinto do Ó

INEB / i3S, University of Porto, Portugal

Liliana Pires

INL – International Iberian Nanotechnology Laboratory, Portugal

Akhilesh Rai

University of Coimbra Faculty of Medicine, and Center for Neuroscience and Cell Biology, Portugal

Luís Augusto Rocha

University of Minho, Portugal

João Rodrigues

University of Madeira CQM – Centro de Química da Madeira, Portugal

Christiane Salgado

i3S – Instituto de Investigação e Inovação em Saúde/INEB – Instituto Nacional de Engenharia Biomédica Biocomposite group, Portugal

Susana Santos

INEB / i3S, University of Porto, Portugal

Sofia Duque Santos

University of Porto nBTT / INEB / i3S, Portugal

Ana Paula Serro

IST, University of Lisbon, Portugal

Susana Sousa

INEB / i3S, University of Porto, Portugal

Rui A. Sousa

Stemmatters, Biotecnologia e Medicina Regenerativa S.A., Portugal

Aureliana Sousa

INEB/i3S, Portugal

Paula Tamagnini

Faculty of Sciences of University of Porto (FCUP), Portugal

Helena Tomas

University of Madeira, Portugal

Ana L. Torres

i3S/INEB, Portugal

Daniela Pereira Vasconcelos

i3S/INEB – Instituto de Investigação e Inovação em Saúde, Portugal

Miguel Xavier

INL – International Iberian Nanotechnology Laboratory, Portugal

Important Dates

Deadline Early Bird Registration
Virtual conference
24 August 2021

Late Registration
Virtual conference
from 25 August 2021

ESB 2021
5–9 September 2021
as fully virtual conferencel

Biomechanics part:
9 September 2021

Conference Status with respect to the Coronavirus pandemic

In the last two weeks, despite the great progress of the vaccination program, the number of coronavirus infections in Portugal has risen significantly due to the Delta variant of the virus. The nationwide 7-day incidence of 110.2 (as of July 1, 2021; source: Johns Hopkins University) is well above the critical limit of 50 newly infected persons per 100,000 inhabitants, per week. 

Taking into consideration the health and safety of all presenters, exhibitors and attendees, and the importance of assuring the quality of the Conference Program, the Organising Committee has taken the difficult decision to move ESB2021 to a fully virtual format, from September 5-9, 2021.

More information

Organizer

esb-300x154-1.jpg

Contact

logo_kit_gross.png

K.I.T. Group GmbH Dresden
Bautzner Str. 117-119
01099 Dresden, Germany